Decision Diagnostics Stock Analysis
| DECN Stock | USD 0.0001 0.00 0.00% |
200 Day MA 0.0001 | 50 Day MA 0.0001 | Beta (0.1) |
Decision Diagnostics has over 2.93 Million in debt which may indicate that it relies heavily on debt financing. At this time, Decision Diagnostics' Long Term Debt is very stable compared to the past year. As of the 3rd of February 2026, Debt To Assets is likely to grow to 1.06, while Short and Long Term Debt is likely to drop about 1.9 M. With a high degree of financial leverage come high-interest payments, which usually reduce Decision Diagnostics' Earnings Per Share (EPS).
Asset vs Debt
Equity vs Debt
Decision Diagnostics' liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Decision Diagnostics' cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Decision Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect Decision Diagnostics' stakeholders.
For many companies, including Decision Diagnostics, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Decision Diagnostics, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Decision Diagnostics' management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Price Book 2.7161 | Enterprise Value | Enterprise Value Ebitda (1.49) | Price Sales 0.0168 | Shares Float 353.6 M |
Given that Decision Diagnostics' debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which Decision Diagnostics is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of Decision Diagnostics to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, Decision Diagnostics is said to be less leveraged. If creditors hold a majority of Decision Diagnostics' assets, the Company is said to be highly leveraged.
At this time, Decision Diagnostics' Common Stock is very stable compared to the past year. As of the 3rd of February 2026, Sale Purchase Of Stock is likely to grow to about 750.6 K, while Total Stockholder Equity is likely to drop about 413.5 K. . As of the 3rd of February 2026, Price To Sales Ratio is likely to drop to 2.65. In addition to that, Price Earnings Ratio is likely to grow to -0.15. Decision Diagnostics is overvalued with Real Value of 8.4E-5 and Hype Value of 1.0E-4. The main objective of Decision Diagnostics stock analysis is to determine its intrinsic value, which is an estimate of what Decision Diagnostics is worth, separate from its market price. There are two main types of Decision Diagnostics' stock analysis: fundamental analysis and technical analysis.
The Decision Diagnostics stock is traded in the USA on OTCCE Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Decision Diagnostics is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day ( substitute day ), Independence Day. Decision Stock trading window is adjusted to America/New York timezone.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Decision Diagnostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in private. Decision Stock Analysis Notes
The company recorded a loss per share of 0.02. Decision Diagnostics had not issued any dividends in recent years. The entity had 1.1:1 split on the 28th of December 2011. Decision Diagnostics Corp. develops smart phone based electronic medical record technologies. Decision Diagnostics Corp. was founded in 2000 and is based in Westlake Village, California. Decision Diagnostics operates under Pharmaceutical Retailers classification in the United States and is traded on OTC Exchange. It employs 6 people. To learn more about Decision Diagnostics call Keith Berman at 805 446 1973 or check out https://www.decisiondiagnostics.co.Decision Diagnostics Investment Alerts
| Decision Diagnostics generated a negative expected return over the last 90 days | |
| Decision Diagnostics has some characteristics of a very speculative penny stock | |
| Decision Diagnostics has a very high chance of going through financial distress in the upcoming years | |
| Decision Diagnostics currently holds 2.93 M in liabilities with Debt to Equity (D/E) ratio of 9.05, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Decision Diagnostics has a current ratio of 0.25, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Decision Diagnostics' use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 1.98 M. Net Loss for the year was (29.67 M) with profit before overhead, payroll, taxes, and interest of 462.23 K. | |
| Decision Diagnostics currently holds about 210.85 K in cash with (1.4 M) of positive cash flow from operations. | |
| Latest headline from news.google.com: HIMS vs. TEM Which Health-Tech Stock Looks More Compelling - Yahoo Finance |
Decision Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 35.79 K.Decision Profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (14.05) | (13.34) | |
| Return On Capital Employed | (2.61) | (2.48) | |
| Return On Assets | (4.72) | (4.49) | |
| Return On Equity | (70.55) | (67.03) |
Management Efficiency
Decision Diagnostics has return on total asset (ROA) of (0.2122) % which means that it has lost $0.2122 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (81.6052) %, meaning that it created substantial loss on money invested by shareholders. Decision Diagnostics' management efficiency ratios could be used to measure how well Decision Diagnostics manages its routine affairs as well as how well it operates its assets and liabilities. As of the 3rd of February 2026, Return On Tangible Assets is likely to grow to -13.34. In addition to that, Return On Capital Employed is likely to grow to -2.48. At this time, Decision Diagnostics' Other Current Assets are very stable compared to the past year. As of the 3rd of February 2026, Total Current Assets is likely to grow to about 2.5 M, while Total Assets are likely to drop about 5.2 M.| Last Reported | Projected for Next Year | ||
| Tangible Book Value Per Share | (0.01) | (0.01) | |
| Enterprise Value Over EBITDA | (2.69) | (2.83) | |
| Price Book Value Ratio | 8.93 | 7.90 | |
| Enterprise Value Multiple | (2.69) | (2.83) | |
| Price Fair Value | 8.93 | 7.90 | |
| Enterprise Value | 6.5 M | 3.9 M |
Decision Diagnostics showcases strong leadership that adapts to market changes and drives innovation. Our analysis explores how this adaptability affects the stock's investment appeal.
Technical Drivers
Decision Diagnostics technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.Decision Diagnostics Price Movement Analysis
The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Decision Diagnostics middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Decision Diagnostics. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Decision Diagnostics Outstanding Bonds
Decision Diagnostics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Decision Diagnostics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Decision bonds can be classified according to their maturity, which is the date when Decision Diagnostics has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Decision Diagnostics Debt to Cash Allocation
As Decision Diagnostics follows its natural business cycle, the capital allocation decisions will not magically go away. Decision Diagnostics' decision-makers have to determine if most of the cash flows will be poured back into or reinvested in the business, reserved for other projects beyond operational needs, or paid back to stakeholders and investors.
Decision Diagnostics currently holds 2.93 M in liabilities with Debt to Equity (D/E) ratio of 9.05, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Decision Diagnostics has a current ratio of 0.25, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Decision Diagnostics' use of debt, we should always consider it together with its cash and equity.Decision Diagnostics Total Assets Over Time
Decision Diagnostics Assets Financed by Debt
The debt-to-assets ratio shows the degree to which Decision Diagnostics uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.Decision Diagnostics Debt Ratio | 106.0 |
Decision Diagnostics Corporate Bonds Issued
Decision Short Long Term Debt
Short Long Term Debt |
|
About Decision Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Decision Diagnostics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Decision shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Decision Diagnostics. By using and applying Decision Stock analysis, traders can create a robust methodology for identifying Decision entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | (13.49) | (14.17) | |
| Operating Profit Margin | (0.96) | (1.01) | |
| Net Loss | (13.49) | (14.17) | |
| Gross Profit Margin | 0.23 | 0.18 |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Decision Diagnostics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Optimization Now
Portfolio OptimizationCompute new portfolio that will generate highest expected return given your specified tolerance for risk |
| All Next | Launch Module |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Decision Diagnostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in private. To learn how to invest in Decision Stock, please use our How to Invest in Decision Diagnostics guide.You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Will Health Care Technology sector continue expanding? Could Decision diversify its offerings? Factors like these will boost the valuation of Decision Diagnostics. Projected growth potential of Decision fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Decision Diagnostics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.02) | Revenue Per Share | Quarterly Revenue Growth (0) | Return On Assets | Return On Equity |
Understanding Decision Diagnostics requires distinguishing between market price and book value, where the latter reflects Decision's accounting equity. The concept of intrinsic value - what Decision Diagnostics' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Decision Diagnostics' price substantially above or below its fundamental value.
It's important to distinguish between Decision Diagnostics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Decision Diagnostics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Decision Diagnostics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.